PDF下载 ( 310 KB)
Prevention and treatment of chronic liver disease and hepatic encephalopathy with biological ecologics
-
-
[1]Bengmark S.Acute and“chronic”phase response-a mother of dis-ease[J].Clin Nutr, 2004, 23∶1256-1266. [1]Bengmark S.Acute and“chronic”phase response-a mother of dis-ease[J].Clin Nutr, 2004, 23∶1256-1266. [2]Hyogo H, Yamagishi S, Iwamoto K, et al. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis[J].J Gastroenterol Hepatol, 2007, 22∶1112-1119. [2]Hyogo H, Yamagishi S, Iwamoto K, et al. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis[J].J Gastroenterol Hepatol, 2007, 22∶1112-1119. [3]Yagmur E, Tacke F, Weiss C, et al.Elevation of Nepsilon (carboxy-methyl) lysine-modified advanced glycation end products in chronicliver disease is an indicator of liver cirrhosis[J].Clin Biochem, 2006, 39∶39-45. [3]Yagmur E, Tacke F, Weiss C, et al.Elevation of Nepsilon (carboxy-methyl) lysine-modified advanced glycation end products in chronicliver disease is an indicator of liver cirrhosis[J].Clin Biochem, 2006, 39∶39-45. [4]Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study[J].Liver Transpl, 2004, 10∶1109-1119. [4]Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study[J].Liver Transpl, 2004, 10∶1109-1119. [5]Jiang R, Camargo CA Jr, Varraso R, et al. Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women[J].Am J Clin Nutr, 2008, 87∶1002-1008. [5]Jiang R, Camargo CA Jr, Varraso R, et al. Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women[J].Am J Clin Nutr, 2008, 87∶1002-1008. [6]Tabak C, Arts IC, Smit HA, et al.Chronic obstructive pulmonarydisease and intake of catechins, flavonols, and flavones:the MOR-GEN Study[J].Am J Respir Crit Care Med, 2001, 164 (1) ∶61-64. [6]Tabak C, Arts IC, Smit HA, et al.Chronic obstructive pulmonarydisease and intake of catechins, flavonols, and flavones:the MOR-GEN Study[J].Am J Respir Crit Care Med, 2001, 164 (1) ∶61-64. [7]Bengmark S.Curcumin, an atoxic antioxidant and natural NFkap-paB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxidesynthase inhibitor:a shield against acute and c Suzuki C, Kimoto-Nira H, Kobayashi M, Nomura M, Sasaki K, Mizumachi K.Immu-nomodulatory and cytotoxic effects of various Lactococcus strains onthe murine macrophage cell line J774.1[J].Int J Food Microbiol, 2008, 123∶159-165. [7]Bengmark S.Curcumin, an atoxic antioxidant and natural NFkap-paB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxidesynthase inhibitor:a shield against acute and c Suzuki C, Kimoto-Nira H, Kobayashi M, Nomura M, Sasaki K, Mizumachi K.Immu-nomodulatory and cytotoxic effects of various Lactococcus strains onthe murine macrophage cell line J774.1[J].Int J Food Microbiol, 2008, 123∶159-165. [8]von der Weid T, Bulliard C, Schiffrin EJ. Induction by a lactic acid bacterium of a population of CD4 (+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10[J].Clin Diagn Lab Immunol, 2001, 8∶695-701. [8]von der Weid T, Bulliard C, Schiffrin EJ. Induction by a lactic acid bacterium of a population of CD4 (+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10[J].Clin Diagn Lab Immunol, 2001, 8∶695-701. [9]Nagler-Anderson C.Tolerance and immunity in the intestinal im-mune system[J].Crit Rev Immunol, 2000, 20∶103-20. [9]Nagler-Anderson C.Tolerance and immunity in the intestinal im-mune system[J].Crit Rev Immunol, 2000, 20∶103-20. [10]Fujiwara D, Inoue S, Wakabayashi H, et al. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance[J].Int Arch Allergy Immunol, 2004, 135∶205-215. [10]Fujiwara D, Inoue S, Wakabayashi H, et al. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance[J].Int Arch Allergy Immunol, 2004, 135∶205-215. [11]VerdEF, Berck P, Bergonzelli CE, et al.Lactobacillus paracaseinormalizes muscle hypercontractility in a murine model of postinfec-tive gut dysfunction[J].Gastroenterology, 2004, 127∶826-837. [11]VerdEF, Berck P, Bergonzelli CE, et al.Lactobacillus paracaseinormalizes muscle hypercontractility in a murine model of postinfec-tive gut dysfunction[J].Gastroenterology, 2004, 127∶826-837. [12]Eutamene H, Lamine F, Chabo C, et al.Synergy between Lactoba-cillus paracasei and its bacterial products to counteract stress-in-duced gut permeability and sensitivity increase in rats[J].J Nutr, 2007, 137∶1901-1907. [12]Eutamene H, Lamine F, Chabo C, et al.Synergy between Lactoba-cillus paracasei and its bacterial products to counteract stress-in-duced gut permeability and sensitivity increase in rats[J].J Nutr, 2007, 137∶1901-1907. [13]Naaber P, Smidt I, Stsepetova J, et al.Inhibition of Clostridiumdifficile strains by intestinal Lactobacillus species[J].J Med Microbi-ol, 2004, 53∶551-554. [13]Naaber P, Smidt I, Stsepetova J, et al.Inhibition of Clostridiumdifficile strains by intestinal Lactobacillus species[J].J Med Microbi-ol, 2004, 53∶551-554. [14]Timmermann HM, Koning CJM, Mulder L, et al. Monostrain, multistrain and multispecies probiotics-a comparison of functionality and efficacy[J].Int J Food Microbiol, 2004, 96∶219-233. [14]Timmermann HM, Koning CJM, Mulder L, et al. Monostrain, multistrain and multispecies probiotics-a comparison of functionality and efficacy[J].Int J Food Microbiol, 2004, 96∶219-233. [15]Gareau MG, Jury J, MacQueen G, et al.Probiotic treatment of ratpups normalises corticosterone release and ameliorates colonic dys-function induced by maternal separation[J].Gut, 2007, 56∶1522-1528. [15]Gareau MG, Jury J, MacQueen G, et al.Probiotic treatment of ratpups normalises corticosterone release and ameliorates colonic dys-function induced by maternal separation[J].Gut, 2007, 56∶1522-1528. [16]Eutamene H, Bueno L.Role of probiotics in correcting abnormali-ties of colonic flora induced by stress[J].Gut, 2007, 56∶1495-1497. [16]Eutamene H, Bueno L.Role of probiotics in correcting abnormali-ties of colonic flora induced by stress[J].Gut, 2007, 56∶1495-1497. [17]Liu Q, Duan ZP, Ha DK, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis[J].Hepatology, 2004, 39∶1441-1449. [17]Liu Q, Duan ZP, Ha DK, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis[J].Hepatology, 2004, 39∶1441-1449. [18]Riordan SM, Skinner NA, McIver CJ, et al.Synbiotic-associatedimprovement in liver function in cirrhotic patients:Relation to chan-ges in circulating cytokine messenger RNAand protein levels[J].Mi-crob Ecol Health Dis, 2007, 19∶7-16. [18]Riordan SM, Skinner NA, McIver CJ, et al.Synbiotic-associatedimprovement in liver function in cirrhotic patients:Relation to chan-ges in circulating cytokine messenger RNAand protein levels[J].Mi-crob Ecol Health Dis, 2007, 19∶7-16. [19]Loguercio C, Federico A, Tuccillo C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases[J].J Clin Gastroenterol, 2005, 39∶540-543. [19]Loguercio C, Federico A, Tuccillo C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases[J].J Clin Gastroenterol, 2005, 39∶540-543. [20]Lata J, Novotn I, Prbramsk V, et al.The effect of probiotics ongut flora, level of endotoxin and Child-Pugh score in cirrhotic pa-tients:results of a double-blind randomized study[J].Eur J Gastro-enterol Hepatol, 2007, 19∶1111-1113. [20]Lata J, Novotn I, Prbramsk V, et al.The effect of probiotics ongut flora, level of endotoxin and Child-Pugh score in cirrhotic pa-tients:results of a double-blind randomized study[J].Eur J Gastro-enterol Hepatol, 2007, 19∶1111-1113. [21]Malaguarnera M, Greco F, Barone G, et al.Bifidobacterium lon-gum with fructo-oligosaccharide (FOS) treatment in minimal hepaticencephalopathy:a randomized, double-blind, placebo-controlledstudy[J].Dig Dis Sci, 2007, 52∶3259-3565. [21]Malaguarnera M, Greco F, Barone G, et al.Bifidobacterium lon-gum with fructo-oligosaccharide (FOS) treatment in minimal hepaticencephalopathy:a randomized, double-blind, placebo-controlledstudy[J].Dig Dis Sci, 2007, 52∶3259-3565. [22]Stadlbauer V, Mookerjee RP, Hodges S, et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis[J].J Hepatol, 2007, 48∶945-951. [22]Stadlbauer V, Mookerjee RP, Hodges S, et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis[J].J Hepatol, 2007, 48∶945-951. -
本文二维码
计量
- 文章访问数: 2231
- HTML全文浏览量: 7
- PDF下载量: 833
- 被引次数: 0
下载:
